Go Pro
NASDAQ:VBIO

Valion Bio, Inc. Common Stock Q2 2026 Earnings Report

Valion Bio, Inc. Common Stock logo
$2.59 +0.08 (+3.19%)
As of 10/2/2026 04:00 PM Eastern

Valion Bio, Inc. Common Stock EPS Results

Actual EPS
N/A
Consensus EPS
-$10,200.00
Beat/Miss
N/A
One Year Ago EPS
N/A

Valion Bio, Inc. Common Stock Revenue Results

Actual Revenue
N/A
Expected Revenue
$0.46 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Valion Bio, Inc. Common Stock Announcement Details

Quarter
Q2 2026
Time
After Market Closes
Conference Call Date
Friday, August 14, 2026
Conference Call Time
4:00PM ET

Earnings Documents

Valion Bio, Inc. Common Stock Earnings Headlines

Ticker Revealed: Pre-IPO Access to "Next Elon Musk" Company
We’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.tc pixel
VBIO - Valion Bio, Inc.
See More Valion Bio, Inc. Common Stock Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Valion Bio, Inc. Common Stock? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Valion Bio, Inc. Common Stock and other key companies, straight to your email.

About Valion Bio, Inc. Common Stock

Tivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.

View Valion Bio, Inc. Common Stock Profile